Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.

NCT05562479 is registered in ClinicalTrials.gov with Novafem as lead sponsor.

NCT NCT05562479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05562479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.
Lead sponsor
Novafem
Phase
Observational
Overall status
Completed
Start date
December 12, 2021
Completion date
September 18, 2022
Enrollment
428 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blastocyst, ovarian reserve, sars-cov-2 infection